Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells.
Bertacchini J, Frasson C, Chiarini F, D'Avella D, Accordi B, Anselmi L, Barozzi P, Forghieri F, Luppi M, Martelli AM, Basso G, Najmaldin S, Khosravi A, Rahim F, Marmiroli S. Bertacchini J, et al. Among authors: marmiroli s. Adv Biol Regul. 2018 May;68:2-9. doi: 10.1016/j.jbior.2018.03.001. Epub 2018 Mar 19. Adv Biol Regul. 2018. PMID: 29576448
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence.
Darici S, Alkhaldi H, Horne G, Jørgensen HG, Marmiroli S, Huang X. Darici S, et al. Among authors: marmiroli s. J Clin Med. 2020 Sep 11;9(9):2934. doi: 10.3390/jcm9092934. J Clin Med. 2020. PMID: 32932888 Free PMC article. Review.
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.
Mediani L, Gibellini F, Bertacchini J, Frasson C, Bosco R, Accordi B, Basso G, Bonora M, Calabrò ML, Mattiolo A, Sgarbi G, Baracca A, Pinton P, Riva G, Rampazzo E, Petrizza L, Prodi L, Milani D, Luppi M, Potenza L, De Pol A, Cocco L, Capitani S, Marmiroli S. Mediani L, et al. Among authors: marmiroli s. Oncotarget. 2016 Feb 2;7(5):5521-37. doi: 10.18632/oncotarget.6315. Oncotarget. 2016. PMID: 26575168 Free PMC article.
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.
Bertacchini J, Guida M, Accordi B, Mediani L, Martelli AM, Barozzi P, Petricoin E 3rd, Liotta L, Milani G, Giordan M, Luppi M, Forghieri F, De Pol A, Cocco L, Basso G, Marmiroli S. Bertacchini J, et al. Among authors: marmiroli s. Leukemia. 2014 Nov;28(11):2197-205. doi: 10.1038/leu.2014.123. Epub 2014 Apr 4. Leukemia. 2014. PMID: 24699302
Cross-talk between the CK2 and AKT signaling pathways in cancer.
Ruzzene M, Bertacchini J, Toker A, Marmiroli S. Ruzzene M, et al. Among authors: marmiroli s. Adv Biol Regul. 2017 May;64:1-8. doi: 10.1016/j.jbior.2017.03.002. Epub 2017 Mar 28. Adv Biol Regul. 2017. PMID: 28373060 Review.
85 results